Stay updated on OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial
Sign up to get notified when there's something new on the OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial page.

Latest updates to the OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial page
- Check3 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check10 days agoChange DetectedA site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” It appears above the clinical trial page’s error message.SummaryDifference1%

- Check17 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check24 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check45 days agoChange DetectedThe study record page now displays a 403 Forbidden error, replacing the previous content. This indicates access to the record is blocked and navigation content is replaced by an error screen.SummaryDifference18%

- Check66 days agoChange DetectedRevision label updated to v3.6.6, replacing the previous v3.6.5. This appears to be a backend release update and does not modify the study details or user-facing content.SummaryDifference0.1%

Stay in the know with updates to OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OpRegen Safety & Efficacy in Advanced Dry AMD Clinical Trial page.